FDA
-
-
-
-
-
-
-
SciSparc unit files U.S. patent for MDMA-PEA combination for PTSD
-
-
-
-
-
-
-
Clearmind Reaches Key Clinical Trial Milestone as DSMB Unanimously Clears Progression in AUD Study
-
-
-
-
-
-
-
Clearmind Medicine submits response to HHS addiction treatment RFI
-
-
-
-
-
-
-
Clearmind Medicine to Feature New Insights from CMND-100 Psychedelic Clinical Trial on “Inside MEAI” Webinar
-
-
-
-
-
-
-
Clearmind Medicine Welcomes President Trump’s Executive Order as a Historic Catalyst for Psychedelic Innovation and Veteran Mental Health Care
-
-
-
-
-
-
-
Clearmind Medicine completes treatment for 18 participants in phase 1 trial
-
-
-
-
-
-
-
Clearmind Medicine Moving Forward to the Next Stage of Its Clinical Trial Following Data and Safety Monitoring Board Approval
-
334,467 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


